BOLTON SECURITIES CORPORATION’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$261K Buy
+3,560
New +$236K 0.01% 674
2025
Q1
$1.48M Buy
+23,168
New +$1.35M 0.09% 253

Other funds holding HALO

BOLTON SECURITIES CORPORATION's HALO Position: Q3 2025 in Review

BOLTON SECURITIES CORPORATION opened a new position in Halozyme (HALO) in Q3 2025: 3,560 shares worth $261K. The stake represents 0.01% of the portfolio and ranks #674 among its holdings. This is a return to the name: BOLTON SECURITIES CORPORATION previously reported a position in HALO as recently as Q1 2025.

BOLTON SECURITIES CORPORATION first reported a position in HALO in Q1 2025 and has held it in 2 quarters since. The position peaked at $1.48M in Q1 2025. 607 funds tracked by Wall St. Rank hold HALO as of Q3 2025.

  • BOLTON SECURITIES CORPORATION held 3,560 shares of Halozyme worth $261K as of Q3 2025.
  • Halozyme was a new BOLTON SECURITIES CORPORATION position in Q3 2025.
  • Halozyme made up 0.01% of BOLTON SECURITIES CORPORATION's portfolio in Q3 2025, its #674 holding.
  • BOLTON SECURITIES CORPORATION first reported a position in Halozyme in Q1 2025 and has held it in 2 quarters since.
  • BOLTON SECURITIES CORPORATION's Halozyme position peaked at $1.48M in Q1 2025.
  • 607 funds tracked by Wall St. Rank held Halozyme as of Q3 2025.

Based on BOLTON SECURITIES CORPORATION's 13F filing for Q3 2025, filed 12 Nov 2026.